We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

85 hedge funds and large institutions have $149M invested in Tempest Therapeutics in 2016 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 41 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

310% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 10

200% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 6

16% more funds holding

Funds holding: 73 → 85 (+12)

35% less capital invested

Capital invested by funds: $230M → $149M (-$80.7M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $208K

Holders
85
Holders Change
+12
Holders Change %
+16.44%
% of All Funds
2.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
41
Reduced
10
Closed
6
Calls
–
Puts
$208K
Net Calls
-$208K
Net Calls Change
+$352K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$8.41M
2
CC
CQS Cayman
Cayman Islands
+$5.35M
3
OAG
Orbis Allan Gray
Bermuda
+$4.27M
4
JHIU
Janus Henderson Investors US
Colorado
+$3.29M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$2.4M

Top Sellers

Rank Fund Capital Flow
1
GC
GMT Capital
Georgia
-$3.06M
2
CAM
Cormorant Asset Management
Massachusetts
-$2.39M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$982K
4
GS
Gagnon Securities
New York
-$254K
5
Northern Trust
Northern Trust
Illinois
-$228K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
51
Bank of America
North Carolina
$172K +$45.7K +2 +22%
Susquehanna International Group
52
Susquehanna International Group
Pennsylvania
$164K +$137K +6 +120%
QSS
53
Quantitative Systematic Strategies
Florida
$164K +$228K +10 New
NCMW
54
Northern Capital Management (Wisconsin)
Wisconsin
$158K +$91.4K +4 +67%
California Public Employees Retirement System
55
California Public Employees Retirement System
California
$157K -$22.8K -1 -9%
ProShare Advisors
56
ProShare Advisors
Maryland
$154K +$45.7K +2 +25%
CS
57
Credit Suisse
Switzerland
$137K +$68.5K +3 +50%
BCM
58
Bridgeway Capital Management
Texas
$130K – – –
Morgan Stanley
59
Morgan Stanley
New York
$126K +$160K +7 +700%
Manulife (Manufacturers Life Insurance)
60
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$124K +$45.7K +2 +33%
Citadel Advisors
61
Citadel Advisors
Florida
$122K +$183K +8 New
BG
62
BlackRock Group
United Kingdom
$117K – – –
NFA
63
Nationwide Fund Advisors
Ohio
$105K +$45.7K +2 +40%
AIG
64
American International Group
New York
$94.2K +$22.8K +1 +20%
VOYA Investment Management
65
VOYA Investment Management
Georgia
$81K +$22.8K +1 +25%
VKH
66
Virtu KCG Holdings
New York
$81K +$114K +5 New
Deutsche Bank
67
Deutsche Bank
Germany
$71K +$91.4K +4 +400%
BA
68
BlackRock Advisors
Delaware
$70K +$22.8K +1 +25%
Dimensional Fund Advisors
69
Dimensional Fund Advisors
Texas
$70K +$114K +5 New
Goldman Sachs
70
Goldman Sachs
New York
$64K -$160K -7 -64%
State Board of Administration of Florida Retirement System
71
State Board of Administration of Florida Retirement System
Florida
$63K – – –
WS
72
Wedbush Securities
California
$58K +$91.4K +4 New
AC
73
Amici Capital
New York
$52K – – –
SSA
74
Schonfeld Strategic Advisors
New York
$52K – – –
BGIM
75
Brandywine Global Investment Management
Pennsylvania
$45K – – –
1 2
3
4

TPST Hedge Fund Activity: Q2 2016 in Review

85 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q2 2016, worth a combined $149M — down 35% from $230M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new TPST positions and 6 closed out — a net gain of 12 holders — while 41 added to existing stakes and 10 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $8.41M. The largest seller was GMT Capital, cutting an estimated $3.06M.

  • 85 institutional investors held Tempest Therapeutics (TPST) as of Q2 2016, up from 73 in Q1 2016.
  • Funds reported $149M of Tempest Therapeutics stock for Q2 2016, down 35% quarter-over-quarter.
  • 18 funds opened new Tempest Therapeutics positions in Q2 2016 and 6 closed out, a net change of +12 holders.
  • The largest Tempest Therapeutics buyer in Q2 2016 was Fidelity Investments, an estimated $8.41M added.
  • The largest Tempest Therapeutics seller in Q2 2016 was GMT Capital, an estimated $3.06M sold.

Based on aggregated 13F filings for Q2 2016.